Condition: Asthma
Interventions: Drug: Placebo; Drug: PF-03715455
Sponsor: Pfizer
Not yet recruiting – verified August 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
Condition: Asthma
Intervention: Drug: salbutamol sulfate + ipratropium bromide
Sponsor: Boehringer Ingelheim
Terminated – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy
Condition: Asthma
Interventions: Drug: Respimat® Budesonide low dose; Drug: Respimat® Budesonide high dose; Drug: Turbohaler® Budesonide; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Chronic Dosing, Cross-Over Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Improved lung function in patients with moderate asthma severity observed with … – News-Medical.net
|
Improved lung function in patients with moderate asthma severity observed with …
News-Medical.net Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies … |
View full post on asthma – Google News
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi; Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified March 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Moderate Alcohol Consumption Protective Against Asthma – Medscape
 Daily Mail |
Moderate Alcohol Consumption Protective Against Asthma
Medscape September 27, 2011 (Amsterdam, the Netherlands) — Healthy people who never drink alcohol or drink rarely are more likely to develop asthma than those who drink moderately, according to a Danish study. Sofie Lieberoth, BSc, a medical student from … Alcohol and asthma link hard to swallow Moderate alcohol may reduce asthma risk Studies show links between biking and lung injury, alcohol and asthma |
View full post on asthma – Google News
Moderate alcohol may reduce asthma risk – UPI.com
Daily Mail |
Moderate alcohol may reduce asthma risk
UPI.com 25 (UPI) — Moderate amounts of alcohol may reduce the risk of asthma, researchers in Denmark suggest. Sofie Lieberoth of the Bispebjerg Hospital in Amsterdam and colleagues found drinking one to six units of alcohol a week could reduce the risk of … Moderate alcohol intake cuts asthma risk A few drinks a week could reduce asthma risk Moderate drinking reduces asthma risk |
View full post on asthma – Google News
Moderate alcohol may reduce asthma risk – UPI.com
Daily Mail |
Moderate alcohol may reduce asthma risk
UPI.com 25 (UPI) — Moderate amounts of alcohol may reduce the risk of asthma, researchers in Denmark suggest. Sofie Lieberoth of the Bispebjerg Hospital in Amsterdam and colleagues found drinking one to six units of alcohol a week could reduce the risk of … Moderate alcohol intake cuts asthma risk A few drinks a week could reduce asthma risk Moderate drinking reduces asthma risk |
View full post on asthma – Google News
EPA Imposes Environmental Tax On Asthma Sufferers – The Moderate Voice
|
EPA Imposes Environmental Tax On Asthma Sufferers
The Moderate Voice As a result, asthma sufferers will have to pay 50-200% more for prescription inhalers. The EPA move reflects an administration increasingly torn between uncompromising environmental activists who demand new regulatory measures regardless of their cost … |
View full post on asthma – Google News